PT96035A - Processo para a preparacao de 14alfa,17alfa-etano-16alfa-hidroxi-estratrienos e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de 14alfa,17alfa-etano-16alfa-hidroxi-estratrienos e de composicoes farmaceuticas que os contem

Info

Publication number
PT96035A
PT96035A PT96035A PT9603590A PT96035A PT 96035 A PT96035 A PT 96035A PT 96035 A PT96035 A PT 96035A PT 9603590 A PT9603590 A PT 9603590A PT 96035 A PT96035 A PT 96035A
Authority
PT
Portugal
Prior art keywords
contain
14alpha
17alpha
oestratriene
16alpha
Prior art date
Application number
PT96035A
Other languages
English (en)
Other versions
PT96035B (pt
Inventor
Rudolf Wiechert
Gerald Kirsch
Gunter Neef
Henry Laurent
James R Bull
Peter Esperling
Walter Elger
Sybille Beier
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3939893A external-priority patent/DE3939893A1/de
Priority claimed from DE3939894A external-priority patent/DE3939894A1/de
Priority claimed from DE4033871A external-priority patent/DE4033871A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT96035A publication Critical patent/PT96035A/pt
Publication of PT96035B publication Critical patent/PT96035B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Fats And Perfumes (AREA)
PT96035A 1989-11-29 1990-11-29 Processo para a preparacao de 14alfa,17alfa-etano-16alfa-hidroxi-estratrienos e de composicoes farmaceuticas que os contem PT96035B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3939893A DE3939893A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-etha(e)no-16ss-hydroxy-estratriene
DE3939894A DE3939894A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-ethano-16(alpha)-hydroxy-estratriene
DE4033871A DE4033871A1 (de) 1990-10-22 1990-10-22 Verfahren zur herstellung von 14(alpha), 17(alpha)-etheno- und ethano-estriolen

Publications (2)

Publication Number Publication Date
PT96035A true PT96035A (pt) 1991-09-13
PT96035B PT96035B (pt) 1998-01-30

Family

ID=27200525

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96035A PT96035B (pt) 1989-11-29 1990-11-29 Processo para a preparacao de 14alfa,17alfa-etano-16alfa-hidroxi-estratrienos e de composicoes farmaceuticas que os contem

Country Status (21)

Country Link
US (1) US5529993A (pt)
EP (1) EP0430386B1 (pt)
JP (1) JP2996723B2 (pt)
KR (1) KR100203003B1 (pt)
CN (2) CN1031061C (pt)
AT (1) ATE122053T1 (pt)
AU (1) AU649239B2 (pt)
CA (1) CA2069880A1 (pt)
CZ (1) CZ286259B6 (pt)
DE (1) DE59009011D1 (pt)
DK (1) DK0430386T3 (pt)
ES (1) ES2074531T3 (pt)
FI (1) FI102902B1 (pt)
HU (1) HU220217B (pt)
IE (1) IE67321B1 (pt)
IL (1) IL96501A (pt)
NO (1) NO301232B1 (pt)
PH (1) PH31668A (pt)
PT (1) PT96035B (pt)
RU (1) RU2087479C1 (pt)
WO (1) WO1991008219A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4447715C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
CN113999276B (zh) * 2020-07-28 2023-08-15 威智医药股份有限公司 一种去乙酰毛花苷中间体的提纯方法以及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE808679C (de) * 1948-10-19 1951-07-19 Hansen Neuerburg & Co Mit Leitflaechen versehene Propelleranordnung fuer Schiffe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE3808679A1 (de) * 1988-03-11 1989-09-21 Schering Ag Verfahren zur herstellung von 14,17(alpha)-etheno-1,3,5(10)-estratrienen

Also Published As

Publication number Publication date
NO921910D0 (no) 1992-05-14
CA2069880A1 (en) 1991-05-30
CN1117050A (zh) 1996-02-21
CZ286259B6 (cs) 2000-02-16
US5529993A (en) 1996-06-25
KR927003620A (ko) 1992-12-18
AU6884191A (en) 1991-06-26
ATE122053T1 (de) 1995-05-15
EP0430386B1 (de) 1995-05-03
CN1052677A (zh) 1991-07-03
WO1991008219A1 (de) 1991-06-13
AU649239B2 (en) 1994-05-19
JPH05503080A (ja) 1993-05-27
HUT67420A (en) 1995-04-28
IL96501A0 (en) 1991-08-16
ES2074531T3 (es) 1995-09-16
HU220217B (hu) 2001-11-28
EP0430386A1 (de) 1991-06-05
IL96501A (en) 1997-07-13
RU2087479C1 (ru) 1997-08-20
DE59009011D1 (de) 1995-06-08
CN1031061C (zh) 1996-02-21
FI102902B (fi) 1999-03-15
CZ594390A3 (cs) 1999-11-17
FI102902B1 (fi) 1999-03-15
IE67321B1 (en) 1996-03-20
PT96035B (pt) 1998-01-30
FI920843A0 (fi) 1992-02-26
NO301232B1 (no) 1997-09-29
JP2996723B2 (ja) 2000-01-11
DK0430386T3 (da) 1995-09-04
KR100203003B1 (ko) 1999-06-15
PH31668A (en) 1999-01-18
NO921910L (no) 1992-05-14
IE904316A1 (en) 1991-06-05
CN1057769C (zh) 2000-10-25
HU9201805D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
BRPI9913945B8 (pt) Composição farmacêutica rapidamente atuante para a administração sublingual de um agente farmacêutico para o tratamento de distúrbios agudos
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
EA200100108A1 (ru) Применение биогенных сульфаматов эстрогенов для гормонзаместительной терапии
TW327125B (en) Composition and method for protecting against pine exhausted
EA200100298A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
AR004229A1 (es) Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
PT78743B (de) 1-alkyl-androsta-1,4-dien-3,17-dione verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
PT96035A (pt) Processo para a preparacao de 14alfa,17alfa-etano-16alfa-hidroxi-estratrienos e de composicoes farmaceuticas que os contem
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
KR960014152A (ko) 17-스피로메틸렌 락톤 또는 락톨 그룹을 갖는 스테로이드
BR9810292A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase
KR900004697A (ko) 고콜레스테롤 혈증치료용 4,5-디아릴-2- 치환된 티오이미다졸
DE69415812D1 (de) 15,15-dialkylsubstituierte östradiolderivate
KR880004810A (ko) 소화성 궤양 치료제
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
NO179838C (no) Fremgangsmåte for fremstilling av S-(-)-3-morfolino-4-(3-tert-butylamino-2-hydroksypropoksy)-1,2,5-tiadiazol-hemihydrat
WO2003099322A3 (en) Il-11 derivatives and therapeutic uses thereof
MX9207493A (es) Composicion farmaceutica que contiene compuestos de trioxolano y diperoxido.
KR900701273A (ko) 진토성 에르골린 유도체
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
BR9815220A (pt) Uso de tiazolidinedionas para o tratamento da hiperglicemia
ATE209495T1 (de) Antiatherosclerotische mittel
KR940002268A (ko) 21-클로로-프레그난 유도체
BR9908155A (pt) Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910410

FG3A Patent granted, date of granting

Effective date: 19971028

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020430